5-bromo-4-chloro-3-indolyl beta-galactoside has been researched along with Cardiomyopathy, Congestive in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kaname, T; Kawasaki, I; Kimura, S; Miike, T; Nomura, K; Ogawa, M; Suzuki, M; Yamamura, K | 1 |
1 other study(ies) available for 5-bromo-4-chloro-3-indolyl beta-galactoside and Cardiomyopathy, Congestive
Article | Year |
---|---|
The lacZ gene under the control of the 7 kb of human dystrophin muscle specific promoter is expressed in cardiac muscle but not in adult skeletal muscle in transgenic mice.
Topics: Animals; Base Sequence; Blotting, Northern; Cardiomyopathy, Dilated; Cells, Cultured; Dystrophin; Embryo, Mammalian; Galactosides; Gene Expression Regulation, Developmental; Gene Expression Regulation, Enzymologic; Genes, Reporter; Indoles; Lac Operon; Mice; Mice, Transgenic; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Myocardium; Promoter Regions, Genetic | 2001 |